Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Century Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-16 4:32 pm Purchase | 2026-01-09 | 13G | CENTURY THERAPEUTICS INC IPSC | Venrock Healthcare Capital Partners III, L.P. | 13,043,478 7.100% | 9,086,292 (+229.61%) | Filing |
| 2025-02-14 6:14 pm Sale | 2024-12-31 | 13G | CENTURY THERAPEUTICS INC IPSC | Venrock Healthcare Capital Partners III, L.P. | 3,957,186 4.700% | -1,432,073 (-26.57%) | Filing |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | CENTURY THERAPEUTICS INC IPSC | Venrock Healthcare Capital Partners III, L.P. | 5,389,259 6.400% | 1,984,126 (+58.27%) | Filing |
| 2024-03-04 4:16 pm Purchase | 2024-02-21 | 13G | CENTURY THERAPEUTICS INC IPSC | Venrock Healthcare Capital Partners III, L.P. | 3,405,133 5.400% | 3,405,133 (New Position) | Filing |